News
The technology can detect 588 common and rare skin conditions in 133 categories.
The tech giant got both tools included in the Australian Register of Therapeutic Goods as Class IIa medical devices.
They will build machine learning algorithms to predict health risks for the elderly.
The company said in a statement that it is now "well positioned" to make a breakthrough in the telemedicine scene with the removal of previous restrictions impeding the growth of the industry.
Frugal Innovation
Intermountain and MDClone pairing saves money as both patients and populations are better understood
Two years ago, Intermountain started a venture fund to invest in companies that met its mission.
HIMSS21
Dr. Jeffrey Vergales, a pediatric cardiologist at UVA Children’s, will be presenting at HIMSS21 on Aug. 10.
The data from PicnicHealth and Komodo's Healthcare Map will be available to researchers in the biopharmaceutical and academic communities.
Also, Genesis MedTech closes Series B funding round.
The investment will support the development of Ada's symptom assessment and care navigation platform.
The initiative will look at inconsistencies in data that hindered COVID-19 response.